This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ettinger, B. Articles by Cummings, S. R. Search for Related Content PubMed PubMed Citation Articles by Ettinger, B. Articles by Cummings, S. R.

Associations between Low Levels of Serum Estradiol, Bone Density, and Fractures among Elderly Women: The Study of Osteoporotic Fractures¹

Division of Research, Kaiser Permanente Medical Care Program (B.E.), Oakland, California 94611; the Division of General Internal Medicine (D.C.B., S.R.C.) and the Department of Epidemiology and Biostatistics (S.R.C.), University of California, San Francisco, California 94105; the Department of Epidemiology and Biostatistics, Graduate School of Public Health, University of Pittsburgh (J.A.C.), Pittsburgh, Pennsylvania 15213

Address all correspondence and requests for reprints to: Bruce Ettinger, M.D., Division of Research, Kaiser Permanente Medical Care Program, 3505 Broadway, Oakland, California 94611-5714.

To evaluate the skeletal effects of endogenous serum estradiol, we measured bone mineral density (BMD) at the calcaneus and radius (single photon absorptiometry) and at the hip and spine (dual x-ray absorptiometry) in 274 women aged 65 yr or more who participated in the Study of Osteoporotic Fractures. Lateral radiographs of the thoracic and lumbar spine were also taken, and serum was assayed for estradiol. Those who had estradiol levels from 10–25 pg/mL had 4.9%, 9.6%, 7.3%, and 6.8% greater BMD at total hip, calcaneus, proximal radius, and spine than those with levels below 5 pg/mL. After multiple adjustments, BMD differences remained statistically significant and corresponded to about 0.4 SD. Vertebral deformities were less prevalent among women whose estradiol level exceeded 5 pg/mL; the multiple adjusted odds ratio was 0.4 (95% confidence interval, 0.2–0.8). We conclude that physiologically low estradiol has a salutary effect on the skeleton in elderly women, possibly by reducing skeletal remodeling.

This article has been cited by other articles:

				M. R. Sowers, H. Zheng, D. McConnell, B. Nan, S. D. Harlow, and J. F. Randolph Jr. Estradiol Rates of Change in Relation to the Final Menstrual Period in a Population-Based Cohort of Women J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3847 - 3852. [Abstract] [Full Text] [PDF]

				R. Eastell, J. E. Adams, R. E. Coleman, A. Howell, R. A. Hannon, J. Cuzick, J. R. Mackey, M. W. Beckmann, and G. Clack Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230 J. Clin. Oncol., March 1, 2008; 26(7): 1051 - 1057. [Abstract] [Full Text] [PDF]

				F. Z. Stanczyk, J. S. Lee, and R. J. Santen Standardization of Steroid Hormone Assays: Why, How, and When? Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1713 - 1719. [Abstract] [Full Text] [PDF]

				A. Bjornerem, L. A. Ahmed, R. M. Joakimsen, G. K R. Berntsen, V. Fonnebo, L. Jorgensen, P. Oian, E. Seeman, and B. Straume A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study Eur. J. Endocrinol., July 1, 2007; 157(1): 119 - 125. [Abstract] [Full Text] [PDF]

				J. A. Riancho, C. Valero, A. Naranjo, D. J. Morales, C. Sanudo, and M. T. Zarrabeitia Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 660 - 665. [Abstract] [Full Text] [PDF]

				J. S. Lee, B. Ettinger, F. Z. Stanczyk, E. Vittinghoff, V. Hanes, J. A. Cauley, W. Chandler, J. Settlage, M. S. Beattie, E. Folkerd, et al. Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3791 - 3797. [Abstract] [Full Text] [PDF]

				C. G. Gjesdal, S. E. Vollset, P. M. Ueland, H. Refsum, C. A. Drevon, H. K. Gjessing, and G. S. Tell Plasma Total Homocysteine Level and Bone Mineral Density: The Hordaland Homocysteine Study Arch Intern Med, January 9, 2006; 166(1): 88 - 94. [Abstract] [Full Text] [PDF]

				K. Kerlikowske, J. Shepherd, J. Creasman, J. A. Tice, E. Ziv, and S. R. Cummings Are Breast Density and Bone Mineral Density Independent Risk Factors for Breast Cancer? J Natl Cancer Inst, March 2, 2005; 97(5): 368 - 374. [Abstract] [Full Text] [PDF]

				R. A. Wermers, D. L. Hurley, and A. E. Kearns Osteoporosis Associated With Megestrol Acetate Mayo Clin. Proc., December 1, 2004; 79(12): 1557 - 1561. [Abstract] [PDF]

				P. B. Rapuri, J. C. Gallagher, and G. Haynatzki Endogenous Levels of Serum Estradiol and Sex Hormone Binding Globulin Determine Bone Mineral Density, Bone Remodeling, the Rate of Bone Loss, and Response to Treatment with Estrogen in Elderly Women J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4954 - 4962. [Abstract] [Full Text] [PDF]

				M. Cifuentes, J. P. Advis, and S. A. Shapses Estrogen Prevents the Reduction in Fractional Calcium Absorption Due to Energy Restriction in Mature Rats J. Nutr., August 1, 2004; 134(8): 1929 - 1934. [Abstract] [Full Text] [PDF]

				H. W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F. H. de Jong, and H. A. P. Pols Endogenous Sex Hormones, Sex Hormone-Binding Globulin, and the Risk of Incident Vertebral Fractures in Elderly Men and Women: The Rotterdam Study J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3261 - 3269. [Abstract] [Full Text] [PDF]

				R. E. Nelson, S. K. Grebe, D. J. O'Kane, and R. J. Singh Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of Estradiol and Estrone in Human Plasma Clin. Chem., February 1, 2004; 50(2): 373 - 384. [Abstract] [Full Text] [PDF]

				K. M. Prestwood, A. M. Kenny, A. Kleppinger, and M. Kulldorff Ultralow-Dose Micronized 17{beta}-Estradiol and Bone Density and Bone Metabolism in Older Women: A Randomized Controlled Trial JAMA, August 27, 2003; 290(8): 1042 - 1048. [Abstract] [Full Text] [PDF]

				J. B.J. van Meurs, S. C.E. Schuit, A. E.A.M. Weel, M. van der Klift, A. P. Bergink, P. P. Arp, E. M. Colin, Y. Fang, A. Hofman, C. M. van Duijn, et al. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk Hum. Mol. Genet., July 15, 2003; 12(14): 1745 - 1754. [Abstract] [Full Text] [PDF]

				A. H. Friedlander and L. J. Jones The Biology, Medical Management, and Podiatric Implications of Menopause J Am Podiatr Med Assoc, September 1, 2002; 92(8): 437 - 443. [Abstract] [Full Text] [PDF]

				B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]

				H. Blain, A. Vuillemin, F. Guillemin, R. Durant, B. Hanesse, N. de Talance, B. Doucet, and C. Jeandel Serum Leptin Level Is a Predictor of Bone Mineral Density in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1030 - 1035. [Abstract] [Full Text] [PDF]

				T. Naessen, K. Rodriguez-Macias, and H. Lithell Serum Lipid Profile Improved by Ultra-Low Doses of 17{beta}-Estradiol in Elderly Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2757 - 2762. [Abstract] [Full Text] [PDF]

				C. Scheidt-Nave, H. Bismar, G. Leidig-Bruckner, H. Woitge, M. J. Seibel, R. Ziegler, and J. Pfeilschifter Serum Interleukin 6 Is a Major Predictor of Bone Loss in Women Specific to the First Decade Past Menopause J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2032 - 2042. [Abstract] [Full Text]

				L. Masi, L. Becherini, L. Gennari, A. Amedei, E. Colli, A. Falchetti, M. Farci, S. Silvestri, S. Gonnelli, and M. L. Brandi Polymorphism of the Aromatase Gene in Postmenopausal Italian Women: Distribution and Correlation with Bone Mass and Fracture Risk J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2263 - 2269. [Abstract] [Full Text]

				T. A Ricci, S. B Heymsfield, R. N Pierson Jr, T. Stahl, H. A Chowdhury, and S. A Shapses Moderate energy restriction increases bone resorption in obese postmenopausal women Am. J. Clinical Nutrition, February 1, 2001; 73(2): 347 - 352. [Abstract] [Full Text] [PDF]

				J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF]

				S. Amin, Y. Zhang, C. T. Sawin, S. R. Evans, M. T. Hannan, D. P. Kiel, P. W.F. Wilson, and D. T. Felson Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study Ann Intern Med, December 19, 2000; 133(12): 951 - 963. [Abstract] [Full Text] [PDF]

				K. M. Prestwood, A. M. Kenny, C. Unson, and M. Kulldorff The Effect of Low Dose Micronized 17{beta}-Estradiol on Bone Turnover, Sex Hormone Levels, and Side Effects in Older Women: A Randomized, Double Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4462 - 4469. [Abstract] [Full Text]

				J M Kaufman, O Johnell, E Abadie, S Adami, M Audran, B Avouac, W B. Sedrine, G Calvo, J P Devogelaer, V Fuchs, et al. Background for studies on the treatment of male osteoporosis: state of the art Ann Rheum Dis, October 1, 2000; 59(10): 765 - 772. [Abstract] [Full Text]

				K. L. Margolis, K. E. Ensrud, P. J. Schreiner, H. K. Tabor, and for the Study of Osteoporotic Fractures Research G Body Size and Risk for Clinical Fractures in Older Women Ann Intern Med, July 18, 2000; 133(2): 123 - 127. [Abstract] [Full Text] [PDF]

				V. Rochira, M. Faustini-Fustini, A. Balestrieri, and C. Carani Estrogen Replacement Therapy in a Man with Congenital Aromatase Deficiency: Effects of Different Doses of Transdermal Estradiol on Bone Mineral Density and Hormonal Parameters J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1841 - 1845. [Abstract] [Full Text]

				E. Barrett-Connor, J. E. Mueller, D. G. von Mühlen, G. A. Laughlin, D. L. Schneider, and D. J. Sartoris Low Levels of Estradiol Are Associated with Vertebral Fractures in Older Men, But Not Women: The Rancho Bernardo Study J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 219 - 223. [Abstract] [Full Text]

				J. R. Center, T. V. Nguyen, P. N. Sambrook, and J. A. Eisman Hormonal and Biochemical Parameters in the Determination of Osteoporosis in Elderly Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3626 - 3635. [Abstract] [Full Text] [PDF]

				J. A. Cauley and J. Zmuda Hormonal Replacement--Effect on Bone Density J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1802 - 1803. [Full Text]

				P. D. Miller, C. Zapalowski, C. A. M. Kulak, and J. P. Bilezikian Bone Densitometry: The Best Way to Detect Osteoporosis and to Monitor Therapy J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1867 - 1871. [Full Text]

				S. Davis Androgen Replacement in Women: A Commentary J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1886 - 1891. [Abstract] [Full Text]

				L. G. Raisz and K. M. Prestwood Estrogen and the Risk of Fracture -- New Data, New Questions N. Engl. J. Med., September 10, 1998; 339(11): 767 - 768. [Full Text]

				R. Marcus M.D. Editorial: New Perspectives on the Skeletal Role of Estrogen J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2236 - 2238. [Full Text]